Repository logo
 
Publication

Endometrial cancer staging: Is there value in ADC?

dc.contributor.authorMoreira, Ana
dc.contributor.authorRibeiro, Vera
dc.contributor.authorAringhieri, Giacomo
dc.contributor.authorFanni, Salvatore
dc.contributor.authorTumminello, Lorenzo
dc.contributor.authorFaggioni, Lorenzo
dc.contributor.authorCioni, Dania
dc.contributor.authorNeri, Emanuele
dc.date.accessioned2025-02-24T10:06:10Z
dc.date.available2025-02-24T10:06:10Z
dc.date.issued2023-04-25
dc.description.abstractPurpose: To assess the ability of apparent diffusion coefficient (ADC) measurements in predicting the histological grade of endometrial cancer. A secondary goal was to assess the agreement between MRI and surgical staging as an accurate measurement. Methods: Patients with endometrial cancers diagnosed between 2018-2020 and having received both MRI and surgical staging were retrospectively enrolled. Patients were characterized according to histology, tumor size, FIGO stage (MRI and surgical stage), and functional MRI parameters (DCE and DWI/ADC). Statistical analysis was performed to determine if an association could be identified between ADC variables and histology grade. Secondarily, we assessed the degree of agreement between the MRI and surgical stages according to the FIGO classification. Results: The cohort included 45 women with endometrial cancer. Quantitative analysis of ADC variables did not find a statistically significant association with histological tumor grades. DCE showed higher sensitivity than DWI/ADC in the assessment of myometrial invasion (85.00% versus 65.00%) with the same specificity (80.00%). A good agreement between MRI and histopathology for the FIGO stage was found (kappa of 0.72, p < 0.01). Differences in staging between MRI and surgery were detected in eight cases, which could not be justified by the interval between MRI and surgery. Conclusions. ADC values were not useful for predicting endometrial cancer grade, despite the good agreement between MRI interpretation and histopathology of endometrial cancer staging at our center.eng
dc.identifier.doi10.3390/jpm13050728
dc.identifier.issn2075-4426
dc.identifier.urihttp://hdl.handle.net/10400.1/26808
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relation.hasversionhttps://www.mdpi.com/2075-4426/13/5/728
dc.relation.ispartofJournal of Personalized Medicine
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectEndometrial cancer
dc.subjectMagnetic resonance imaging
dc.subjectDiffusion-weighted imaging
dc.subjectApparent diffusion coefficient
dc.subjectDynamic contrast-enhanced magnetic resonance imaging
dc.subjectStaging
dc.subjectGrading
dc.titleEndometrial cancer staging: Is there value in ADC?eng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue5
oaire.citation.startPage728
oaire.citation.titleJournal of Personalized Medicine
oaire.citation.volume13
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Endometrial Cancer Staging: Is There Value in ADC.pdf
Size:
7.09 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description: